Cargando…

CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis

CCN2, formerly termed Connective Tissue Growth Factor, is a protein belonging to the Cellular Communication Network (CCN)-family of secreted extracellular matrix-associated proteins. As a matricellular protein it is mainly considered to be active as a modifier of signaling activity of several differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leguit, Roos J., Raymakers, Reinier A. P., Hebeda, Konnie M., Goldschmeding, Roel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798015/ https://www.ncbi.nlm.nih.gov/pubmed/33428075 http://dx.doi.org/10.1007/s12079-020-00602-2

Ejemplares similares

Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016
por: Tzankov, Alexandar, et al.
Publicado: (2018)

A potential role for CCN2/CTGF in aggressive colorectal cancer
por: Ubink, Inge, et al.
Publicado: (2016)

Regulation of Malignant Hematopoiesis by Bone Marrow Microenvironment
por: Asada, Noboru
Publicado: (2018)

CCN2/CTGF is required for matrix organization and to protect growth plate chondrocytes from cellular stress
por: Hall-Glenn, Faith, et al.
Publicado: (2013)

CCN2 reduction mediates protective effects of BMP7 treatment in obstructive nephropathy
por: Falke, Lucas L., et al.
Publicado: (2016)

Anatomy of Hematopoiesis and Local Microenvironments in the Bone Marrow. Where to?
por: Wu, Qingqing, et al.
Publicado: (2021)

Hematopoiesis and microenvironment in hematological malignancies
por: Cheng, Hui, et al.
Publicado: (2018)

EZH2 in normal hematopoiesis and hematological malignancies
por: Herviou, Laurie, et al.
Publicado: (2015)

The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment
por: Alvarez-Martins, Inês, et al.
Publicado: (2016)

How Does Lifestyle Affect Hematopoiesis and the Bone Marrow Microenvironment?
por: Vanhie, James J., et al.
Publicado: (2022)

Integrin α3β1 in hair bulge stem cells modulates CCN2 expression and promotes skin tumorigenesis
por: Ramovs, Veronika, et al.
Publicado: (2020)

CCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation
por: Rayego-Mateos, Sandra, et al.
Publicado: (2023)

CCN3 and bone marrow cells
por: Katsube, Ken-ichi, et al.
Publicado: (2009)

TET2: A cornerstone in normal and malignant hematopoiesis
por: Kunimoto, Hiroyoshi, et al.
Publicado: (2020)

Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment
por: Kovtonyuk, Larisa V., et al.
Publicado: (2016)

From the niche to malignant hematopoiesis and back: reciprocal interactions between leukemia and the bone marrow microenvironment
por: Soto, Celia A., et al.
Publicado: (2021)

Epitranscriptomics in Normal and Malignant Hematopoiesis
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2020)

CCN2 Aggravates the Immediate Oxidative Stress–DNA Damage Response following Renal Ischemia–Reperfusion Injury
por: Valentijn, Floris A., et al.
Publicado: (2021)

Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
por: Hebeda, Konnie M., et al.
Publicado: (2009)

TET2 as an epigenetic master regulator for normal and malignant hematopoiesis
por: Nakajima, Hideaki, et al.
Publicado: (2014)

Stathmin 1 in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2014)

Polycomb complexes in normal and malignant hematopoiesis
por: Di Carlo, Valerio, et al.
Publicado: (2019)

miRNAs in Normal and Malignant Hematopoiesis
por: Kotaki, Ryutaro, et al.
Publicado: (2017)

Role of HDACs in normal and malignant hematopoiesis
por: Wang, Pan, et al.
Publicado: (2020)

Autophagy and Metabolism in Normal and Malignant Hematopoiesis
por: Stergiou, Ioanna E., et al.
Publicado: (2021)

Immunoproteasome Function in Normal and Malignant Hematopoiesis
por: Tubío-Santamaría, Nuria, et al.
Publicado: (2021)

Sex differences in normal and malignant hematopoiesis
por: Cui, Xiaojing, et al.
Publicado: (2022)

Transposable elements in normal and malignant hematopoiesis
por: Lemerle, Eline, et al.
Publicado: (2023)

The skinny on CCN2
por: Leask, Andrew
Publicado: (2008)

Bone Marrow Fat and Hematopoiesis
por: Wang, Huifang, et al.
Publicado: (2018)

Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment
por: Meng, Yiting, et al.
Publicado: (2023)

Zebrafish as a model for normal and malignant hematopoiesis
por: Jing, Lili, et al.
Publicado: (2011)

The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis
por: Sun, Xiao-Jian, et al.
Publicado: (2015)

Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis
por: Wielockx, Ben, et al.
Publicado: (2019)

Single-Cell Sequencing in Normal and Malignant Hematopoiesis
por: Wilson, Nicola K., et al.
Publicado: (2018)

Correction to: Role of HDACs in normal and malignant hematopoiesis
por: Wang, Pan, et al.
Publicado: (2020)

Normal and Neoplastic Hematopoiesis
por: Morin, Michael J.
Publicado: (1984)

Pathology Image Exchange: The Dutch Digital Pathology Platform for Exchange of Whole-Slide Images for Efficient Teleconsultation, Telerevision, and Virtual Expert Panels
por: van Diest, Paul J., et al.
Publicado: (2019)

Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2
por: Leask, Andrew
Publicado: (2009)

Expression and biological function of the cellular communication network factor 5 (CCN5) in primary liver cells
por: Borkham-Kamphorst, Erawan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_19933bk2e87tl0b72i4nu6id9p